Versant Capital Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$145K Buy
1,854
+156
+9% +$12.2K 0.02% 542
2025
Q1
$123K Buy
1,698
+145
+9% +$10.5K 0.02% 563
2024
Q4
$115K Buy
1,553
+786
+102% +$58.2K 0.02% 268
2024
Q3
$50.6K Buy
767
+283
+58% +$18.7K 0.01% 447
2024
Q2
$44.7K Buy
484
+326
+206% +$30.1K 0.01% 414
2024
Q1
$15.1K Buy
158
+112
+243% +$10.7K ﹤0.01% 598
2023
Q4
$3.51K Buy
46
+10
+28% +$763 ﹤0.01% 1108
2023
Q3
$2.49K Sell
36
-3
-8% -$208 ﹤0.01% 1229
2023
Q2
$3.68K Buy
39
+9
+30% +$849 ﹤0.01% 1151
2023
Q1
$2.48K Hold
30
﹤0.01% 1205
2022
Q4
$2.24K Sell
30
-9
-23% -$671 ﹤0.01% 1115
2022
Q3
$3K Sell
39
-16
-29% -$1.23K ﹤0.01% 974
2022
Q2
$5K Hold
55
﹤0.01% 851
2022
Q1
$6K Sell
55
-22
-29% -$2.4K ﹤0.01% 823
2021
Q4
$10K Hold
77
﹤0.01% 709
2021
Q3
$9K Sell
77
-16
-17% -$1.87K ﹤0.01% 722
2021
Q2
$10K Hold
93
﹤0.01% 707
2021
Q1
$8K Hold
93
﹤0.01% 863
2020
Q4
$8K Hold
93
﹤0.01% 783
2020
Q3
$7K Hold
93
﹤0.01% 757
2020
Q2
$6K Hold
93
﹤0.01% 782
2020
Q1
$5K Buy
93
+24
+35% +$1.29K ﹤0.01% 766
2019
Q4
$5K Hold
69
﹤0.01% 917
2019
Q3
$5K Hold
69
﹤0.01% 938
2019
Q2
$4K Sell
69
-501
-88% -$29K ﹤0.01% 1016
2019
Q1
$36K Hold
570
0.02% 368
2018
Q4
$29K Hold
570
0.01% 388
2018
Q3
$33K Sell
570
-12
-2% -$695 0.01% 425
2018
Q2
$28K Hold
582
0.01% 479
2018
Q1
$27K Hold
582
0.01% 499
2017
Q4
$21K Hold
582
0.01% 632
2017
Q3
$21K Hold
582
0.01% 563
2017
Q2
$22K Sell
582
-66
-10% -$2.5K 0.01% 553
2017
Q1
$20K Hold
648
0.01% 581
2016
Q4
$20K Hold
648
0.01% 588
2016
Q3
$26K Sell
648
-21
-3% -$843 0.01% 480
2016
Q2
$22K Hold
669
0.01% 511
2016
Q1
$19K Buy
669
+51
+8% +$1.45K 0.01% 535
2015
Q4
$16K Buy
+618
New +$16K 0.01% 580